Bronchoalveolar lavage fluid showed reduced pulmonary fibrosis and expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 after treatment with EVs inhibitors. The gene discussed is TNF; the disease is pulmonary fibrosis.